the label required under subsection (b)(3) unless 
such a label is already affixed to the container. 
‘‘(f) DRUG RECALLS.—On receipt of notification 
from the manufacturer of a prescription drug imported 
from Canada or a permitted country under this section 
that the prescription drug has been recalled or withdrawn 
from the market in Canada or a permitted country, a drug 
importation facility shall promptly provide the Secretary 
and any person to whom the prescription drug was distrib-
uted a notice that the drug has been recalled or withdrawn 
from the market and that includes— 
‘‘(1) information (including the lot number) 
that identifies the prescription drug; and 
‘‘(2) a statement of the reason for the recall or 
withdrawal. 
‘‘(g) 
CHARITABLE
CONTRIBUTIONS.—Notwith-
standing any other provision of this section, section 
801(d)(1) continues to apply to a prescription drug that 
is donated or otherwise supplied at no charge or a nominal 
charge by the manufacturer of the prescription drug to 
a charitable or humanitarian organization (including the 
United Nations and affiliates) or to a government of a 
foreign country. 
‘‘(h) JURISDICTION.—The district courts of the 
United States shall have jurisdiction in an action brought
by the United States against a person importing or offer-
ing for importation a prescription drug in violation of the 
requirements of this section. 
‘‘(i) EFFECT OF SECTION.—Nothing in this section 
limits the authority of the Secretary relating to the impor-
tation of prescription drugs (including the interdiction of 
prescription drugs that are unapproved, adulterated, or 
misbranded), other than with respect to section 801(d)(1) 
as provided in subsection (g).’’. 
SEC. 4. PERSONAL IMPORTATION; INTERNET PHARMACIES. 
Subchapter B of chapter VIII of the Federal Food, 
Drug, and Cosmetic Act, as amended by section 3 of this 
Act, is amended by adding at the end the following section: 
‘‘SEC. 813. PERSONAL IMPORTATION; INTERNET PHAR-
MACIES. 
‘‘An individual may, for personal use or for the use 
of a family member of the individual (rather than for re-
sale), import a prescription drug into the United States 
from any Internet pharmacy that is registered under sec-
tion 816 and licensed under section 503B, except to the 
extent that the Secretary determines that importation of 
the prescription drug is not in accordance with this sub-
chapter.’’.
SEC. 5. PERSONAL IMPORTATION; ENTERING UNITED 
STATES IN POSSESSION OF PRESCRIPTION 
DRUGS; COMPASSIONATE USE. 
Subchapter B of chapter VIII of the Federal Food, 
Drug, and Cosmetic Act, as amended by section 4 of this 
Act, is amended by adding at the end the following section: 
‘‘SEC. 814. PERSONAL IMPORTATION; ENTERING UNITED 
STATES IN POSSESSION OF PRESCRIPTION 
DRUGS; COMPASSIONATE USE. 
‘‘(a) IN GENERAL.—An individual may, for personal 
use or for the use of a family member of the individual 
(rather than for resale), import a prescription drug from 
Canada or a permitted country into the United States, 
subject to subsections (b) and (c). 
‘‘(b) IMPORTATION.—An individual may import a 
prescription drug if— 
‘‘(1) the prescription drug is purchased from a 
licensed pharmacy in Canada or a licensed pharmacy 
in a permitted country and dispensed in compliance 
with the applicable laws of Canada or the permitted 
country regarding the practice of pharmacy; 
‘‘(2) the prescription drug is imported from 
Canada or a permitted country into the United 
States; 
‘‘(3) the prescription drug is imported by the 
individual on the person of the individual;
‘‘(4) the quantity of the prescription drug im-
ported does not exceed a 90-day supply during any 
90-day period; and 
‘‘(5) the prescription drug is accompanied by— 
‘‘(A) a copy of a prescription valid in a 
State and cosigned by a prescribing physician 
in Canada or the permitted country; or 
‘‘(B) if the prescription drug is available in 
Canada or the permitted country without a pre-
scription, a copy of the valid prescription signed 
by a pharmacist licensed in Canada or the per-
mitted country. 
‘‘(c) COMPASSIONATE USE.—The Secretary may per-
mit an individual to import an up to a 90-day supply of 
a drug that is not approved by the Secretary under section 
505 if the importation is for continuation of personal use 
by the individual for treatment, begun in a foreign coun-
try, of a serious medical condition.’’. 
SEC. 6. PARTICULAR PRODUCTS; SUSPENSION OF AUTHOR-
ITY FOR IMPORTATION. 
Subchapter B of chapter VIII of the Federal Food, 
Drug, and Cosmetic Act, as amended by section 5 of this 
Act, is amended by adding at the end the following section: